EWMA 2025: Groundbreaking AI-Driven Advancements in Wound Healing Models
MD Biosciences presented at the European Wound Management Association 2025 in Barcelona. Dr. Avital Schauder showcased groundbreaking research on...
preclinical drug development
Behavioral Assessments in Preclinical Models
Neurological diseases often result in a combination of motor and cognitive deficits. To gain a broader understanding of the underlying biological...
Importance of Diversity in Preclinical Stroke Models
The Need for Diversity in Animal Models The clinical population is diverse, including both sexes, older individuals, and those with comorbid...
Why are potential pain therapies getting lost in translation?
It is estimated that 1.5 billion people worldwide suffer from Chronic pain. While research has seen tremendous advances in our understanding of pain...
3 ways to improve clinical relevance of preclinical CNS data
The success rate from first candidate to market launch is less than 1%, requiring approximately 22 hits for every drug launched. Within...